REFERENCES
- Crnich C J, Maki D G. The promise of novel technology for prevention of intravascular device related bloodstream infections, II: long-term devices. Clin Infect Dis 2000; 34: 1362–1368, [CSA]
- Castagnola E, Molinari A C, Fratino G, et al. Annotion: conditions associated with infections of indwelling central venous catheters in cancer patients: a summary. Br J Haematol. 2003; 121: 233–239, [INFOTRIEVE], [CSA], [CROSSREF]
- Henderson D K. Infections due to percutaneous intravascular devices. Principles and Practice of Infectious Diseases, ed 5, G L Mandell, J E Bennet, R Dolin. Churchill Livingstone, Philadelphia 2000; Vol. II
- Stamou S, Maltezou H. C., Pourtsidis A, et al. Hickman-Broviac catheter related infections in children with malignancies. Mount Sinai J Med. 1999; 66: 320–326, [CSA]
- Minassian V A, Sood A K, Lowe P, et al. Long term central venous access in gynecologic cancer patients. J Am Coll Surg. 2000; 191: 403–409, [INFOTRIEVE], [CSA], [CROSSREF]
- Goossens G A, Vrebos M, Stas M, et al. Central venous access devices in oncology and hematology considered from a different point of view. J Infus Nurs. 2005; 28: 61–67, [INFOTRIEVE], [CSA]
- Babu R, Spicer R D. Implanted vascular access devices (ports) in children: complications and their prevention. Pediatr Surg Int 2002; 18: 50–53, [INFOTRIEVE], [CSA], [CROSSREF]
- Abbas A AH, Fryer C JH, Paltiel C, et al. Factors influencing central infections in children with acute lymphoblastic leukemia: results of a single institutional study. Pediatr Blood Cancer 2004; 42: 325–331, [INFOTRIEVE], [CSA], [CROSSREF]
- Munro F D, Gillett P M, Wratten J C, et al. Totally implantable central venous access devices for pediatric oncology patients. Med Pediatr Oncol. 1999; 33: 377–381, [INFOTRIEVE], [CSA], [CROSSREF]
- Johansson E, Björkholm M, Björvell H, et al. Totally implantable subcutaneous port system versus central venous catheter placed before induction chemotherapy in patients with acute leukemia: a randomised study. Support Care Cancer. 2004; 12: 99–105, [INFOTRIEVE], [CSA], [CROSSREF]
- Schaul D B, Scheer B, Rokhsar S, et al. Risk factors for early infection of central venous catheters in pediatric patients. J Am Coll Surg. 1998; 186: 654–658, [CSA], [CROSSREF]
- Rackoff W R, Ge J, Sather H N, et al. Central venous catheter use and risk of infection in children with acute lymphoblastic leukemia: a report from Children's Cancer Group. J Pediatr Hematol Oncol. 1999; 21: 260–267, [INFOTRIEVE], [CSA], [CROSSREF]
- Cesaro S, Corro R, Pelosin A, et al. A prospective survey on incidence and outcome of Broviac/Hickman catheter-related complications in pediatric patients affected by hematological and oncological diseases. Ann Hematol. 2003; 1: 1007/s00277–003-0796-9, [CSA]
- Laurenzi L, Natoli S, Benedetti C, et al. Cutaneous bacterial colonization, modalities of chemotherapeutic infusion and catheter-related bloodstream infection in totally implanted venous access devices. Support Care Cancer. 2004; 12: 805–809, [INFOTRIEVE], [CSA], [CROSSREF]
- Duthoit D, Devleeshouwer C, Paesmans M, et al. Infections of totally implantable chamber catheters in cancer patients: multivariate analysis of risk factors. Programs and Abstract Book of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans Louisiana. American Society for Microbiology, Washington, DC 1993; 1627
- Pagano L, Tacconelli E, Tumbarello M, et al. Bacteriemia in patients with hematologic malignancies: analysis of risk factors, etiological agents and prognostic indicators. Haematologica. 2002; 8: 290–294, [CSA]
- Chang L, Tsai J -S, Huang S -J, et al. Evaluation of infectious complications of the implantable venous access system in general oncologic population. Am J Infect Control. 2003; 31: 34–39, [INFOTRIEVE], [CSA], [CROSSREF]
- Dickerson N, Horton P, Smith S. Clinically significant central venous catheter infections in community hospital: association with type of dressing. J Infect Dis. 1989; 160: 720, [INFOTRIEVE], [CSA]
- Sola J E, Stone M M, Colombani P M. Totally implantable vascular access devices in 131 pediatric oncology patients. Pediatr Surg Int 1996; 11: 156–158, [CSA], [CROSSREF]
- Hengartner H, Berger C, Nadal D, et al. Port-A-Cath infections in children with cancer. Eur J Cancer. 2004; 40: 2452–2458, [INFOTRIEVE], [CSA], [CROSSREF]
- Ingram J, Weizman S, Greenberg M L, et al. Complications of indwelling venous access lines in pediatric hematology patients: prospective comparison of external venous catheters and subcutaneous ports. Am J Pediatr Hematol Oncol. 1991; 13: 130–136, [INFOTRIEVE], [CSA]
- Wurzel C l, Halom K, Feldman J G, et al. Infection rates of Broviac-Hickman catheters and implantable venous devices. Am J Dis Child. 1988; 142: 536–540, [INFOTRIEVE], [CSA]